LGALS3 and neoplasm: Studies suggested that tumor cells secreted Gal3 could bind glycosylated receptors at the surface of tumor-infiltrating lymphocytes (TIL) to form glycoprotein–galectin lattices, thereby impairing the motility and functionality of TILs [191].